CONCLUSION: This study provides the first comprehensive evidence supporting the neuroprotective properties of XHG in ADHD through multi-target mechanisms, offering a scientific basis for its clinical application as a potential therapeutic agent.
CONCLUSION: This study provides the first comprehensive evidence supporting the neuroprotective properties of XHG in ADHD through multi-target mechanisms, offering a scientific basis for its clinical application as a potential therapeutic agent.